Sanofi

ZALTRAP

Manufacturer:

Sanofi

Zaltrap HCPCS:

J9400

HCPCS Code Descriptor:

Injection, ziv-aflibercept, 1 mg

Category:

J Code

Zaltrap NDCs:

00024-5841-01, 00024-5840-01

Primary Type:

Oncology

Generic/Specialty Status:

Single-Source

Package Type:

Vial

Route of Administration:

Intravenous

Zaltrap CPT Codes:

Potential CPT administration codes for Zaltrap can be found at the following link.

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Zaltrap:

ZALTRAP is an Oncology drug manufactured by Sanofi and administered via the Intravenous route of administration. The J Code: J9400 is aligned to the drug ZALTRAP.

ACCESS PRICING AND MORE BY REGISTERING

J9400 Added Date:

January 1, 2014

J9400 Effective Date:

January 1, 2014

J9400 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Zaltrap billing and coding information.
Zaltrap patient assistance information can be found through Sanofi Patient Connection at the URL: https://www.sanofipatientconnection.com/
ZALTRAP prescribing information can be found at the link below:
Information regarding ZALTRAP’s side effects can be found at MedlinePlus